Literature DB >> 20206324

Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.

Hiroshi Morita1, Douglas P Zipes, Shiho T Morita, Jiashin Wu.   

Abstract

BACKGROUND: Genetic defects in the sodium channel or in the calcium channel have been identified in patients with Brugada syndrome (BS). However, the differences in their genotype-phenotype correlations are still unclear.
OBJECTIVE: We evaluated the phenotypic differences and therapeutic effects between the sodium channel and calcium channel abnormalities in in vitro models of BS.
METHODS: We created two models of BS in 18 isolated and arterially perfused canine right ventricular preparations: (1) sodium channel dysfunction model (Na model, n = 11) by pilsicainide and pinacidil and (2) calcium channel dysfunction model (Ca model, n = 7) by verapamil; optically mapped action potentials (APs) on their transmural surface; and evaluated APs and electrocardiograms (ECGs) at pacing cycle lengths (CLs) of 2,000 and 1,000 ms.
RESULTS: CL = 1,000 ms: Both models had coved-type ST elevation in the ECG, longer AP duration (APD) in the epicardium than in the endocardium, and a similar incidence of spontaneous ventricular arrhythmias. However, the Ca model had a higher incidence of T wave alternans (TWA) than the Na-model. CL = 2,000 ms: ECGs of the Ca model converted to saddleback-type ST elevation with shorter APDs in the epicardium than in the endocardium, whereas the Na model still had coved-type ST elevation and longer APDs in the epicardium. None of the Ca model preparations had ventricular arrhythmias or TWA, although the Na model had frequent ventricular arrhythmias and TWA.
CONCLUSION: Although both sodium channel and calcium channel dysfunction produced similar BS ECGs and arrhythmogenesis at 60 bpm, calcium channel dysfunction was associated with a higher incidence of TWA at 60 bpm, less ST elevation, and fewer arrhythmias at 30 bpm compared with sodium channel dysfunction. Copyright (c) 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206324     DOI: 10.1016/j.hrthm.2010.01.039

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  3 in total

1.  A case of Brugada syndrome coexisting with vasospastic angina: Caution should be taken when using calcium channel blockers.

Authors:  Takahisa Yoshikawa; Chisato Izumi; Kazuaki Kaitani; Yoshihisa Nakagawa
Journal:  J Cardiol Cases       Date:  2011-10-02

Review 2.  Experimental Models of Brugada syndrome.

Authors:  Franziska Sendfeld; Elisabet Selga; Fabiana S Scornik; Guillermo J Pérez; Nicholas L Mills; Ramon Brugada
Journal:  Int J Mol Sci       Date:  2019-04-29       Impact factor: 5.923

Review 3.  Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.

Authors:  Yingrui Li; Siegfried Lang; Ibrahim Akin; Xiaobo Zhou; Ibrahim El-Battrawy
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.